YY Inc. (NASDAQ:YY) belongs to Technology sector. Its net profit margin is 28.90% and weekly performance is 11.65%. On last trading day company shares ended up $70.04. YY Inc. (NASDAQ:YY) distance from 50-day simple moving average (SMA50) is 14.64%. Piper Jaffray restated their overweight rating on shares of YY (NYSE:YY) in a report issued on Saturday. They currently have a $88.00 target price on the stock, down from their previous target price of $109.00.
Dyax Corp. (NASDAQ:DYAX) shares moved up 1.98% in last trading session and ended the day at $26.72. DYAX Gross Margin is 89.10% and its return on assets is -6.40%. Dyax Corp. (NASDAQ:DYAX) quarterly performance is 74.41%. Dyax Corp. (NASDAQ: DYAX) announced that executive management will participate in the Jefferies 2015 Global Healthcare Conference being held June 1-4, 2015 at the Grand Hyatt in New York City. The Company is scheduled to present on Monday, June 1 at 3:00pm (ET) and will provide an update on DX-2930, KALBITOR® (ecallantide) and the Licensing and Funded Research Portfolio (LFRP).
On 27 May, Bright Horizons Family Solutions, Inc. (NYSE:BFAM) shares advanced 2.06% and was closed at $55.87. BFAM EPS growth in last 5 year was 16.10%. Bright Horizons Family Solutions, Inc. (NYSE:BFAM) year to date (YTD) performance is 18.85%.
Bright Horizons Family Solutions, Inc. (NYSE:BFAM) announced that certain of its stockholders intend to offer for sale 3,000,000 shares of its common stock pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission, of which the Company intends to repurchase from the underwriter 1,250,000 shares of common stock.
PharMerica Corporation (NYSE:PMC) ended the last trading day at $33.41. Company weekly volatility is calculated as 3.33% and price to cash ratio as 40.29. PharMerica Corporation (NYSE:PMC) showed a weekly performance of 8.93%. On 18 May, it was reported PharMerica Corporation (NYSE:PMC) will pay $31.5 million to resolve a false claims lawsuit. The case was originally filed by Jenny Buth, a pharmacist formerly employed by PharMerica as its pharmacy operations manager in Pewaukee, Wisconsin.
Itron, Inc. (NASDAQ:ITRI) shares moved up 1.18% in last trading session and ended the day at $36.75. ITRI Gross Margin is 31.20% and its return on assets is -1.00%. Itron, Inc. (NASDAQ:ITRI) quarterly performance is 0.49%. the Board of Directors of Itron, Inc. (NASDAQ:ITRI) elected Diana D. Tremblay and Frank Jaehnert as directors, effective June 1, 2015 and serving until the 2016 annual shareholders meeting, at which time both will stand for election by Itron’s shareholders.